These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 26939589)

  • 1. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
    Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
    Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deprescribing preventive medication in older patients.
    van Middelaar T; Moll van Charante EP
    Br J Gen Pract; 2018 Oct; 68(675):456-457. PubMed ID: 30262605
    [No Abstract]   [Full Text] [Related]  

  • 3. How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study.
    Mantelli S; Jungo KT; Rozsnyai Z; Reeve E; Luymes CH; Poortvliet RKE; Chiolero A; Rodondi N; Gussekloo J; Streit S
    BMC Fam Pract; 2018 Oct; 19(1):169. PubMed ID: 30314468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trial.
    Luymes CH; Poortvliet RKE; van Geloven N; de Waal MWM; Drewes YM; Blom JW; Smidt N; Assendelft WJJ; van den Hout WB; de Ruijter W; Numans ME
    BMC Med; 2018 Jan; 16(1):5. PubMed ID: 29321031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study.
    Abou J; Crutzen S; Tromp V; Heringa M; Van Marum R; Elders P; Taxis K; Denig P; Hugtenburg J
    Drugs Aging; 2022 Mar; 39(3):209-221. PubMed ID: 35187614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.
    Jungo KT; Mantelli S; Rozsnyai Z; Missiou A; Kitanovska BG; Weltermann B; Mallen C; Collins C; Bonfim D; Kurpas D; Petrazzuoli F; Dumitra G; Thulesius H; Lingner H; Johansen KL; Wallis K; Hoffmann K; Peremans L; Pilv L; Šter MP; Bleckwenn M; Sattler M; van der Ploeg M; Torzsa P; Kánská PB; Vinker S; Assenova R; Bravo RG; Viegas RPA; Tsopra R; Pestic SK; Gintere S; Koskela TH; Lazic V; Tkachenko V; Reeve E; Luymes C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2021 Jan; 21(1):19. PubMed ID: 33413142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study.
    van Middelaar T; Ivens SD; van Peet PG; Poortvliet RKE; Richard E; Pols AJ; Moll van Charante EP
    BMJ Open; 2018 Apr; 8(4):e020871. PubMed ID: 29678989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
    Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
    Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    PLoS One; 2016; 11(4):e0151066. PubMed ID: 27093289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.
    Kouladjian L; Gnjidic D; Reeve E; Chen TF; Hilmer SN
    Ann Pharmacother; 2016 Aug; 50(8):625-36. PubMed ID: 27257284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
    Bolmsjö BB; Palagyi A; Keay L; Potter J; Lindley RI
    BMC Fam Pract; 2016 Nov; 17(1):152. PubMed ID: 27814691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.
    AlRasheed MM; Alhawassi TM; Alanazi A; Aloudah N; Khurshid F; Alsultan M
    Clin Interv Aging; 2018; 13():1401-1408. PubMed ID: 30122912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing in older patients by early-career general practitioners: Prevalence and associations.
    Magin P; Quain D; Tapley A; van Driel M; Davey A; Holliday E; Ball J; Kaniah A; Turner R; Spike N; FitzGerald K; Hilmer S
    Int J Clin Pract; 2021 Aug; 75(8):e14325. PubMed ID: 33960089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    Int J Clin Pract; 2016 Mar; 70(3):261-76. PubMed ID: 26918508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate Medication in the Elderly Population with Excessive Polypharmacy in Primary Care.
    Reus X; Sastre ML; Leiva A; Sánchez B; García-Serra C; Ioakeim-Skoufa I; Vicens C
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?
    Djatche L; Lee S; Singer D; Hegarty SE; Lombardi M; Maio V
    J Clin Pharm Ther; 2018 Aug; 43(4):550-555. PubMed ID: 29682764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.